Carl Gordon

Verified
Member at Orbimed AdvisorsListed on SEC Form ADVNew York, United States
Claim this profile
Sign up to save
Hot

Check Size

Not yet known

Reliability Score

🎯80% of deals in Healthcare

Investment Timeline

Keros Therapeutics
Board seat (SEC Form D)Source
Since Mar 2020
Company last raised Mar 2020
SpringWorks Therapeutics
Board seat (SEC Form D)Source
Since Sep 2017
Company last raised Sep 2017
Gemini Therapeutics
Board seat (SEC Form D)Source
Since May 2016
Company last raised May 2016
Adicet Bio
Board seat (SEC Form D)Source
Since Aug 2015
Company last raised Oct 2019
Igenica Biotherapeutics
Board seat (SEC Form D)Source
Since Feb 2014
Company last raised Oct 2015

Portfolio Breakdown

By Sector

Healthcare4 deals · 80%
Other1 deal · 20%

By Stage

5 tracked deals2 sectors · 0 stages

Deal Velocity

Avg Deals / Year
0.7
Avg Deal Size
Unknown
Largest Deal
Keros Therapeutics
Unknown
YoY Trend
Accelerating

Deals Per Year

1
14
1
15
1
16
1
17
0
18
0
19
1
20
5 total deals tracked2014–2020

Investment Activity Map

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2014
2015
2016
2017
2018
2019
2020
Less
More

Current Fund Status

Fund Name
Orbimed Genesis Master Fund, L.P.
Reported Size
$747.0M

Co-Investors

No co-investment data available yet.

Warm Intro Paths

Sign in to discover warm intro paths

Sign in